$SPHR
Sphere Entertainment Co. Stock $sphr

$sphr Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-K Financial Statement

#000179525023000017 Filed on August 22, 2023

Income Statement

Concept	2023 Q2	2023	2022
Revenue	$129.1M	$573.8M	$1.725B
YoY Change	-71.54%	-66.73%	111.81%
Cost Of Revenue	$340.5M	$340.5M	$958.7M
YoY Change	26.08%	-64.48%	139.2%
Gross Profit	$233.3M	$233.3M	$766.0M
YoY Change	27.18%	-69.54%	85.27%
Gross Profit Margin	180.71%	40.66%	44.41%
Selling, General & Admin	$453.8M	$453.8M	$681.8M
YoY Change	124.97%	-33.44%	60.67%
% of Gross Profit	194.52%	194.52%	89.01%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$14.14M	$103.4M	$124.6M
YoY Change	-60.75%	-17.05%	2.16%
% of Gross Profit	6.06%	44.31%	16.27%
Operating Expenses	$199.4M	$484.5M	$1.827B
YoY Change	-60.92%	-73.48%	82.29%
Operating Profit	-$70.35M	-$251.2M	-$102.7M
YoY Change	23.95%	144.64%	-45.44%
Interest Expense	$11.59M	$11.59M	$27.16M
YoY Change	-556.28%	-57.34%	32.96%
% of Operating Profit
Other Income/Expense, Net	$536.9M	$536.9M	-$113.2M
YoY Change	-2614.46%	-574.14%	-512.83%
Pretax Income	$275.4M	$275.4M	-$215.9M
YoY Change	-336.51%	-227.55%	34.29%
Income Tax	$103.4M	$103.4M	-$25.79M
% Of Pretax Income	37.54%	37.54%
Net Earnings	$536.8M	$502.8M	-$194.4M
YoY Change	-637.1%	-358.63%	31.21%
Net Earnings / Revenue	415.8%	87.62%	-11.27%
Basic Earnings Per Share		$14.51	-$5.77
Diluted Earnings Per Share	$14.39	$14.40	-$5.77
COMMON SHARES
Basic Shares Outstanding		34.65M shares	34.26M shares
Diluted Shares Outstanding		34.93M shares	34.26M shares

Balance Sheet

Concept	2023 Q2	2023	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$132.0M	$132.0M	$828.5M
YoY Change	-84.07%	-84.07%	-45.38%
Cash & Equivalents	$132.0M	$132.0M	$828.5M
Short-Term Investments
Other Short-Term Assets	$4.344M	$352.9M	$135.3M
YoY Change	-60.33%	160.75%	2.41%
Inventory	$0.00
Prepaid Expenses	$22.62M
Receivables	$112.6M	$112.6M	$222.2M
Other Receivables	$26.40M	$26.40M	$32.54M
Total Short-Term Assets	$623.9M	$623.9M	$1.219B
YoY Change	-48.8%	-48.8%	-34.93%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.307B	$3.392B	$3.386B
YoY Change	12.52%	0.19%	38.93%
Goodwill	$456.8M
YoY Change	-8.67%
Intangibles
YoY Change
Long-Term Investments	$394.5M	$394.5M	$43.80M
YoY Change	800.65%	800.65%	-11.01%
Other Assets	$87.79M	$87.79M	$145.3M
YoY Change	-39.9%	-39.59%	-12.82%
Total Long-Term Assets	$4.349B	$4.349B	$4.304B
YoY Change	1.06%	1.06%	25.94%
TOTAL ASSETS
Total Short-Term Assets	$623.9M	$623.9M	$1.219B
Total Long-Term Assets	$4.349B	$4.349B	$4.304B
Total Assets	$4.973B	$4.973B	$5.522B
YoY Change	-9.94%	-9.94%	4.39%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$39.65M	$440.2M	$31.98M
YoY Change	24.0%	1276.34%	20.03%
Accrued Expenses	$85.71M	$85.71M	$584.0M
YoY Change	7.58%	-85.32%	55.31%
Deferred Revenue	$27.34M
YoY Change	-88.01%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$82.50M	$82.50M	$73.84M
YoY Change	11.72%	11.72%	36.81%
Total Short-Term Liabilities	$692.1M	$692.1M	$956.4M
YoY Change	-27.63%	-27.63%	31.04%
LONG-TERM LIABILITIES
Long-Term Debt	$1.118B	$1.118B	$1.669B
YoY Change	-33.0%	-33.0%	1.13%
Other Long-Term Liabilities	$88.81M	$199.1M	$573.5M
YoY Change	-38.96%	-65.29%	46.74%
Total Long-Term Liabilities	$1.207B	$1.317B	$2.243B
YoY Change	-33.48%	-41.26%	9.86%
TOTAL LIABILITIES
Total Short-Term Liabilities	$692.1M	$692.1M	$956.4M
Total Long-Term Liabilities	$1.207B	$1.317B	$2.243B
Total Liabilities	$2.389B	$2.389B	$3.559B
YoY Change	-28.95%	-32.87%	14.02%
SHAREHOLDERS EQUITY
Retained Earnings	$212.0M
YoY Change	-172.93%
Common Stock	$2.376B
YoY Change	3.23%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$2.584B	$2.584B	$1.963B
YoY Change
Total Liabilities & Shareholders Equity	$4.973B	$4.973B	$5.522B
YoY Change	-9.94%	-9.94%	4.39%

Cashflow Statement

Concept	2023 Q2	2023	2022
OPERATING ACTIVITIES
Net Income	$536.8M	$502.8M	-$194.4M
YoY Change	-637.1%	-358.63%	31.21%
Depreciation, Depletion And Amortization	$14.14M	$103.4M	$124.6M
YoY Change	-60.75%	-17.05%	2.16%
Cash From Operating Activities	$15.77M	$153.6M	$141.3M
YoY Change	-55.13%	8.67%	-340.81%
INVESTING ACTIVITIES
Capital Expenditures	$294.5M	$1.059B	$756.7M
YoY Change	-222.58%	39.94%	65.94%
Acquisitions		$0.00	$0.00
YoY Change
Other Investing Activities	$466.0M	$405.1M	-$1.060M
YoY Change	-3009.93%	-38312.74%	438.07%
Cash From Investing Activities	$171.6M	-$653.9M	-$804.2M
YoY Change	-166.95%	-18.68%	552.82%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-114.9M	$85.54M	-$30.39M
YoY Change	-343.9%	-381.46%	-105.13%
NET CHANGE
Cash From Operating Activities	15.77M	$153.6M	$141.3M
Cash From Investing Activities	171.6M	-$653.9M	-$804.2M
Cash From Financing Activities	-114.9M	$85.54M	-$30.39M
Net Change In Cash	72.38M	-$416.9M	-$694.0M
YoY Change	-141.61%	-39.93%	-265.69%
FREE CASH FLOW
Cash From Operating Activities	$15.77M	$153.6M	$141.3M
Capital Expenditures	$294.5M	$1.059B	$756.7M
Free Cash Flow	-$278.7M	-$905.4M	-$615.4M
YoY Change	-201.21%	47.13%	19.56%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2020	us-gaap	Accounting Standards Update Extensible List AccountingStandardsUpdateExtensibleList	http://fasb.org/us-gaap/2023#AccountingStandardsUpdate201613Member
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OperatingLeaseRightOfUseAsset
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OperatingLeaseRightOfUseAsset
CY2022Q2	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OperatingLeaseLiabilityCurrent
CY2023Q2	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OperatingLeaseLiabilityCurrent
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OperatingLeaseLiabilityNoncurrent
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OperatingLeaseLiabilityNoncurrent
CY2023	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost Credit Amortization Of Gain Loss Statement Of Income Or Comprehensive Income Extensible List DefinedBenefitPlanNetPeriodicBenefitCostCreditAmortizationOfGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleList	http://fasb.org/us-gaap/2023#OtherNonoperatingIncomeExpense
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P3Y
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2022Q2	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	3766000	usd
CY2023	us-gaap	Valuation Allowances And Reserves Charged To Cost And Expense ValuationAllowancesAndReservesChargedToCostAndExpense	-2050000	usd
CY2023	us-gaap	Valuation Allowances And Reserves Charged To Other Accounts ValuationAllowancesAndReservesChargedToOtherAccounts	-840000	usd
CY2023	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	675000	usd
CY2023Q2	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	201000	usd
CY2021Q2	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	4485000	usd
CY2022	us-gaap	Valuation Allowances And Reserves Charged To Cost And Expense ValuationAllowancesAndReservesChargedToCostAndExpense	-2323000	usd
CY2022	us-gaap	Valuation Allowances And Reserves Charged To Other Accounts ValuationAllowancesAndReservesChargedToOtherAccounts	1992000	usd
CY2022	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	388000	usd
CY2022Q2	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	3766000	usd
CY2020Q2	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	3328000	usd
CY2021	us-gaap	Valuation Allowances And Reserves Charged To Cost And Expense ValuationAllowancesAndReservesChargedToCostAndExpense	5048000	usd
CY2021	us-gaap	Valuation Allowances And Reserves Charged To Other Accounts ValuationAllowancesAndReservesChargedToOtherAccounts	-3305000	usd
CY2021	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	586000	usd
CY2021Q2	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	4485000	usd
CY2023	dei	Auditor Name AuditorName	Deloitte & Touche LLP
CY2023	dei	Auditor Location AuditorLocation	New York, NY
CY2023	dei	Auditor Firm AuditorFirmId	34
CY2023Q2	sphr	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Continuing Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsContinuingOperations	429114000	usd
CY2022Q2	sphr	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Continuing Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsContinuingOperations	760312000	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	56085000	usd
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	26862000	usd
CY2023Q2	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	0	usd
CY2022Q2	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	307530000	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	623913000	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	1218656000	usd
CY2023Q2	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	394519000	usd
CY2022Q2	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	40297000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3307161000	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2157577000	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	84912000	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	66151000	usd
CY2023Q2	us-gaap	Goodwill Goodwill	456807000	usd
CY2022Q2	us-gaap	Goodwill Goodwill	456807000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	17910000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	21025000	usd
CY2023Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	87793000	usd
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	49466000	usd
CY2023Q2	us-gaap	Disposal Group Including Discontinued Operation Assets Noncurrent DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent	0	usd
CY2022Q2	us-gaap	Disposal Group Including Discontinued Operation Assets Noncurrent DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent	1512181000	usd
CY2023Q2	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	0	usd
CY2022Q2	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	607559000	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	692141000	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	961100000	usd
CY2023Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1118387000	usd
CY2022Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	929534000	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	110259000	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	84420000	usd
CY2023Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	379552000	usd
CY2022Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	144391000	usd
CY2023Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	88811000	usd
CY2022Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	91474000	usd
CY2023Q2	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Noncurrent LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent	0	usd
CY2022Q2	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Noncurrent LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent	1151665000	usd
CY2023Q2	us-gaap	Liabilities Liabilities	2389150000	usd
CY2022Q2	us-gaap	Liabilities Liabilities	3362584000	usd
CY2023Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q2	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	0	usd
CY2022Q2	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	184192000	usd
CY2023Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	2376420000	usd
CY2022Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	2301970000	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	212036000	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-290736000	usd
CY2023Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-4938000	usd
CY2022Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-48355000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	2583865000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	1963221000	usd
CY2023Q2	us-gaap	Minority Interest MinorityInterest	0	usd
CY2022Q2	us-gaap	Minority Interest MinorityInterest	12163000	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2583865000	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1975384000	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4973015000	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5522160000	usd
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	333653000	usd
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-52297000	usd
CY2021	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-171142000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	505680000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-190147000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-166519000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	502772000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-194395000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-148151000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	4.96
CY2022	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-4.02
CY2021	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.14
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	9.55
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-1.75
CY2021	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-4.74
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	14.51
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-5.77
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-4.60
CY2023	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	4.93
CY2022	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-4.02
CY2021	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.13
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	9.47
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-1.75
CY2021	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-4.72
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	14.40
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-5.77
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-4.59
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	34651000	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	34255000	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	34077000	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	34929000	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	34255000	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	34252000	shares
CY2021	us-gaap	Profit Loss ProfitLoss	-166519000	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	509648000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-212478000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-127950000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	505680000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-190147000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-166519000	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	103375000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	124629000	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	121999000	usd
CY2023	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges	224831000	usd
CY2022	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges	3045000	usd
CY2021	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges	0	usd
CY2023	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	5063000	usd
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	8728000	usd
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	6270000	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	123467000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-31270000	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-71357000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	62658000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	77141000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	70584000	usd
CY2023	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	26811000	usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	26673000	usd
CY2021	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	16459000	usd
CY2023	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	548690000	usd
CY2022	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	-54869000	usd
CY2021	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	44320000	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-35815000	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2023	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	538000	usd
CY2022	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-1450000	usd
CY2021	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-5171000	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-7103000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	30749000	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	18634000	usd
CY2023	us-gaap	Increase Decrease In Due From Affiliates Current IncreaseDecreaseInDueFromAffiliatesCurrent	-35811000	usd
CY2022	us-gaap	Increase Decrease In Due From Affiliates Current IncreaseDecreaseInDueFromAffiliatesCurrent	-14778000	usd
CY2021	us-gaap	Increase Decrease In Due From Affiliates Current IncreaseDecreaseInDueFromAffiliatesCurrent	-8593000	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	178758000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	43982000	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	33348000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	117278000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	78442000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	39895000	usd
CY2023	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	135448000	usd
CY2022	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	18572000	usd
CY2021	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	12753000	usd
CY2023	sphr	Increase Decrease In Right Of Use Assets And Liabilities IncreaseDecreaseInRightOfUseAssetsAndLiabilities	16286000	usd
CY2022	sphr	Increase Decrease In Right Of Use Assets And Liabilities IncreaseDecreaseInRightOfUseAssetsAndLiabilities	564000	usd
CY2021	sphr	Increase Decrease In Right Of Use Assets And Liabilities IncreaseDecreaseInRightOfUseAssetsAndLiabilities	6240000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	153591000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	141340000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-58694000	usd
CY2023	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	1058978000	usd
CY2022	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	756717000	usd
CY2021	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	456007000	usd
CY2023	us-gaap	Interest Paid Capitalized InterestPaidCapitalized	116044000	usd
CY2022	us-gaap	Interest Paid Capitalized InterestPaidCapitalized	48507000	usd
CY2021	us-gaap	Interest Paid Capitalized InterestPaidCapitalized	34890000	usd
CY2023	us-gaap	Payments For Proceeds From Short Term Investments PaymentsForProceedsFromShortTermInvestments	-209045000	usd
CY2022	us-gaap	Payments For Proceeds From Short Term Investments PaymentsForProceedsFromShortTermInvestments	0	usd
CY2021	us-gaap	Payments For Proceeds From Short Term Investments PaymentsForProceedsFromShortTermInvestments	-361189000	usd
CY2023	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	318003000	usd
CY2022	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	0	usd
CY2023	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	5949000	usd
CY2022	sphr	Proceeds To Acquire Equity Method Investments ProceedsToAcquireEquityMethodInvestments	1060000	usd
CY2021	sphr	Proceeds To Acquire Equity Method Investments ProceedsToAcquireEquityMethodInvestments	197000	usd
CY2023	us-gaap	Payments For Proceeds From Loans Receivable PaymentsForProceedsFromLoansReceivable	0	usd
CY2022	us-gaap	Payments For Proceeds From Loans Receivable PaymentsForProceedsFromLoansReceivable	0	usd
CY2021	us-gaap	Payments For Proceeds From Loans Receivable PaymentsForProceedsFromLoansReceivable	-6328000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-653923000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-804164000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-123183000	usd
CY2023	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	302668000	usd
CY2022	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	725000000	usd
CY2021	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	630500000	usd
CY2023	us-gaap	Repayments Of Other Long Term Debt RepaymentsOfOtherLongTermDebt	72875000	usd
CY2022	us-gaap	Repayments Of Other Long Term Debt RepaymentsOfOtherLongTermDebt	725000000	usd
CY2021	us-gaap	Repayments Of Other Long Term Debt RepaymentsOfOtherLongTermDebt	46750000	usd
CY2023	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	0	usd
CY2022	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	39100000	usd
CY2021	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	15000000	usd
CY2023	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	2000000	usd
CY2022	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	15000000	usd
CY2021	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	0	usd
CY2023	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	16625000	usd
CY2022	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	16658000	usd
CY2021	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	8208000	usd
CY2021	us-gaap	Proceeds From Contributed Capital ProceedsFromContributedCapital	18537000	usd
CY2023	us-gaap	Proceeds From Payments To Minority Shareholders ProceedsFromPaymentsToMinorityShareholders	-1881000	usd
CY2022	us-gaap	Proceeds From Payments To Minority Shareholders ProceedsFromPaymentsToMinorityShareholders	-6998000	usd
CY2023	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	0	usd
CY2022	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	12838000	usd
CY2021	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	0	usd
CY2023	sphr	Payment To Related Parties For Share Based Award Settlement PaymentToRelatedPartiesForShareBasedAwardSettlement	2388000	usd
CY2022	sphr	Payment To Related Parties For Share Based Award Settlement PaymentToRelatedPartiesForShareBasedAwardSettlement	2256000	usd
CY2021	sphr	Payment To Related Parties For Share Based Award Settlement PaymentToRelatedPartiesForShareBasedAwardSettlement	1771000	usd
CY2023	us-gaap	Payments For Repurchase Of Redeemable Noncontrolling Interest PaymentsForRepurchaseOfRedeemableNoncontrollingInterest	0	usd
CY2022	us-gaap	Payments For Repurchase Of Redeemable Noncontrolling Interest PaymentsForRepurchaseOfRedeemableNoncontrollingInterest	4638000	usd
CY2021	us-gaap	Payments For Repurchase Of Redeemable Noncontrolling Interest PaymentsForRepurchaseOfRedeemableNoncontrollingInterest	0	usd
CY2023	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	5238000	usd
CY2022	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	17504000	usd
CY2021	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	14623000	usd
CY2023	us-gaap	Payments Of Distributions To Affiliates PaymentsOfDistributionsToAffiliates	119119000	usd
CY2022	us-gaap	Payments Of Distributions To Affiliates PaymentsOfDistributionsToAffiliates	0	usd
CY2021	us-gaap	Payments Of Distributions To Affiliates PaymentsOfDistributionsToAffiliates	0	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	85542000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-30392000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	592685000	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-2106000	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-750000	usd
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8027000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-416896000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-693966000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	418835000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	846010000	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1539976000	usd
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1121141000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	429114000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	846010000	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1539976000	usd
CY2023	sphr	Investments And Loans To Related Parties InvestmentsAndLoansToRelatedParties	113000	usd
CY2022	sphr	Investments And Loans To Related Parties InvestmentsAndLoansToRelatedParties	791000	usd
CY2021	sphr	Investments And Loans To Related Parties InvestmentsAndLoansToRelatedParties	0	usd
CY2023	us-gaap	Transfer To Investments TransferToInvestments	0	usd
CY2022	us-gaap	Transfer To Investments TransferToInvestments	0	usd
CY2021	us-gaap	Transfer To Investments TransferToInvestments	59763000	usd
CY2023	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	248041000	usd
CY2022	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	206462000	usd
CY2021	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	110428000	usd
CY2023	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	3642000	usd
CY2022	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	2979000	usd
CY2021	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	5467000	usd
CY2020Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2299504000	usd
CY2020Q2	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	20600000	usd
CY2021	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	-150250000	usd
CY2021	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	-16269000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	20201000	usd
CY2021	sphr	Comprehensive Income Loss Net Of Tax Including Portion Attributable To Redeemable Noncontrolling Interest ComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToRedeemableNoncontrollingInterest	-130049000	usd
CY2021	sphr	Comprehensive Income Loss Net Of Tax Attributable To Redeemable Noncontrolling Interests ComprehensiveIncomeLossNetOfTaxAttributableToRedeemableNoncontrollingInterests	-16269000	usd
CY2021	sphr	Temporary Equity Noncontrolling Interests Non Cash Acquisition TemporaryEquityNoncontrollingInterestsNonCashAcquisition	76500000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	73702000	usd
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2180406000	usd
CY2021Q2	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	137834000	usd
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2180406000	usd
CY2021Q2	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	137834000	usd
CY2022	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	-197886000	usd
CY2022	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	7739000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-18083000	usd
CY2022	sphr	Comprehensive Income Loss Net Of Tax Including Portion Attributable To Redeemable Noncontrolling Interest ComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToRedeemableNoncontrollingInterest	-215969000	usd
CY2022	sphr	Comprehensive Income Loss Net Of Tax Attributable To Redeemable Noncontrolling Interests ComprehensiveIncomeLossNetOfTaxAttributableToRedeemableNoncontrollingInterests	7739000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	77772000	usd
CY2022	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	16658000	usd
CY2022	us-gaap	Temporary Equity Stock Issued During Period Value New Issues TemporaryEquityStockIssuedDuringPeriodValueNewIssues	2348000	usd
CY2022	us-gaap	Minority Interest Change In Redemption Value MinorityInterestChangeInRedemptionValue	-49248000	usd
CY2022	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	-50636000	usd
CY2022	sphr	Stockholders Equity Transferof Assetsand Liabilities StockholdersEquityTransferofAssetsandLiabilities	-3173000	usd
CY2022	sphr	Adjustment Of Redeemable Noncontrolling Interest To Redemption Value AdjustmentOfRedeemableNoncontrollingInterestToRedemptionValue	8070000	usd
CY2022	sphr	Distribution To Related Parties Associated With The Settlement Of Certain Share Based Compensation DistributionToRelatedPartiesAssociatedWithTheSettlementOfCertainShareBasedCompensation	1496000	usd
CY2022	sphr	Partially Own Subsidiary Distribution To Related Party Portion Attributable To Noncontrolling Interest PartiallyOwnSubsidiaryDistributionToRelatedPartyPortionAttributableToNoncontrollingInterest	760000	usd
CY2022	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	6400000	usd
CY2022	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	2650000	usd
CY2022	sphr	Decrease From Distributions To Redeemable Noncontrolling Interest Holders DecreaseFromDistributionsToRedeemableNoncontrollingInterestHolders	4640000	usd
CY2022	sphr	Put Option Payments PutOptionPayments	-895000	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1975384000	usd
CY2022Q2	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	184192000	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1975384000	usd
CY2022Q2	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	184192000	usd
CY2023	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	501755000	usd
CY2023	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	3925000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	6876000	usd
CY2023	sphr	Comprehensive Income Loss Net Of Tax Including Portion Attributable To Redeemable Noncontrolling Interest ComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToRedeemableNoncontrollingInterest	508631000	usd
CY2023	sphr	Comprehensive Income Loss Net Of Tax Attributable To Redeemable Noncontrolling Interests ComprehensiveIncomeLossNetOfTaxAttributableToRedeemableNoncontrollingInterests	3925000	usd
CY2023	us-gaap	Minority Interest Change In Redemption Value MinorityInterestChangeInRedemptionValue	126375000	usd
CY2023	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	126375000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	64406000	usd
CY2023	sphr	Temporary Equity Accretion Of Put Options TemporaryEquityAccretionOfPutOptions	-895000	usd
CY2023	us-gaap	Temporary Equity Stock Issued During Period Value New Issues TemporaryEquityStockIssuedDuringPeriodValueNewIssues	2786000	usd
CY2023	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	16620000	usd
CY2023	sphr	Distribution To Related Parties Associated With The Settlement Of Certain Share Based Compensation DistributionToRelatedPartiesAssociatedWithTheSettlementOfCertainShareBasedCompensation	1736000	usd
CY2023	sphr	Partially Own Subsidiary Distribution To Related Party Portion Attributable To Noncontrolling Interest PartiallyOwnSubsidiaryDistributionToRelatedPartyPortionAttributableToNoncontrollingInterest	652000	usd
CY2023	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	3000000	usd
CY2023	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	1881000	usd
CY2023	sphr	Decrease From Distributions To Redeemable Noncontrolling Interest Holders DecreaseFromDistributionsToRedeemableNoncontrollingInterestHolders	3141000	usd
CY2023	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	-4582000	usd
CY2023	sphr	Redeemable Noncontrolling Interests Gain Loss On Disposition Of Business RedeemableNoncontrollingInterestsGainLossOnDispositionOfBusiness	-60735000	usd
CY2023	sphr	Adjustments To Additional Paid In Capital Distributions To Affiliates AdjustmentsToAdditionalPaidInCapitalDistributionsToAffiliates	-68217000	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2583865000	usd
CY2023Q2	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	0	usd
CY2023	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2023	sphr	Number Of Networks NumberOfNetworks	2	network
CY2023	sphr	Venue Occupancy Number Of Guests VenueOccupancyNumberOfGuests	20000	guest
CY2023	sphr	Building Height Feet BuildingHeightFeet	100	ft
CY2023	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reclassifications</span></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For purposes of comparability, certain prior period amounts have been reclassified to conform to the current year presentation in accordance with accounting principles generally accepted in the United States of America (“GAAP”).</span></div>
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	843000	usd
CY2022	us-gaap	Sublease Income SubleaseIncome	1900000	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	Use of Estimates<div style="margin-top:6.6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the accompanying consolidated financial statements in conformity with U.S. generally accepted accounting principles (“GAAP”) requires management to make estimates and assumptions about future events. These estimates and the underlying assumptions affect the amounts of assets and liabilities reported, disclosures about contingent assets and liabilities, and reported amounts of revenues and expenses. Such estimates include the provision for credit losses, valuation of investments, goodwill, intangible assets, other long-lived assets, deferred tax assets, pension and other postretirement benefit obligations and the related net periodic benefit cost, and other liabilities. In addition, estimates are used in revenue recognition, rights fees, performance and share-based compensation, depreciation and amortization, litigation matters and other matters, as well as in the valuation of noncontrolling interests resulting from business combination transactions. Management believes its use of estimates in the financial statements to be reasonable.</span></div><div style="margin-top:6.6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management evaluates its estimates on an ongoing basis using historical experience and other factors, including the general economic environment and actions it may take in the future. The Company adjusts such estimates when facts and circumstances dictate. However, these estimates may involve significant uncertainties and judgments and cannot be determined with precision. In addition, these estimates are based on management’s best judgment at a point in time and, as such, these estimates may ultimately differ from actual results. Changes in estimates resulting from weakness in the economic environment or other factors beyond the Company’s control could be material and would be reflected in the Company’s financial statements in future periods.</span></div>
CY2023Q2	us-gaap	Deferred Costs DeferredCosts	61421000	usd
CY2022Q2	us-gaap	Deferred Costs DeferredCosts	0	usd
CY2023	us-gaap	Advertising Expense AdvertisingExpense	16977000	usd
CY2022	us-gaap	Advertising Expense AdvertisingExpense	22880000	usd
CY2021	us-gaap	Advertising Expense AdvertisingExpense	24533000	usd
CY2022	us-gaap	Revenues Revenues	610055000	usd
CY2021	us-gaap	Revenues Revenues	647510000	usd
CY2023	us-gaap	Sublease Income SubleaseIncome	2610000	usd
CY2023	us-gaap	Revenues Revenues	573831000	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	171000	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	571221000	usd
CY2023	us-gaap	Sublease Income SubleaseIncome	2610000	usd
CY2023	us-gaap	Revenues Revenues	573831000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	608155000	usd
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	Concentrations of RiskFinancial instruments that may potentially subject the Company to a concentration of credit risk consist primarily of cash and cash equivalents and accounts receivable. Cash and cash equivalents are invested in U.S. treasury bills, money market accounts and time deposits. The Company monitors the financial institutions and money market funds where it invests its cash and cash equivalents with diversification among counterparties to mitigate exposure to any single financial institution. The Company’s emphasis is primarily on safety of principal and liquidity, and secondarily on maximizing the yield on its investments.
CY2022	us-gaap	Sublease Income SubleaseIncome	1900000	usd
CY2022	us-gaap	Revenues Revenues	610055000	usd
CY2021	us-gaap	Revenues Revenues	647510000	usd
CY2023	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	4254000	usd
CY2023Q2	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2023Q2	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2023Q2	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2023Q2	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2023Q2	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2023Q2	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2023Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	36070000	usd
CY2023Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	30322000	usd
CY2023Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	17011000	usd
CY2023Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	3433000	usd
CY2023Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	0	usd
CY2023Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	0	usd
CY2023Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	86836000	usd
CY2023	us-gaap	Restructuring Charges RestructuringCharges	27924000	usd
CY2022	us-gaap	Restructuring Charges RestructuringCharges	-13404000	usd
CY2023Q2	us-gaap	Investments Investments	394519000	usd
CY2022Q2	us-gaap	Investments Investments	40297000	usd
CY2023	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	1969000	usd
CY2022	us-gaap	Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount	0	usd
CY2022Q2	us-gaap	Restructuring Reserve RestructuringReserve	0	usd
CY2023	sphr	Restructuring Charges Excluding Share Based Compensation Expense RestructuringChargesExcludingShareBasedCompensationExpense	19806000	usd
CY2023	us-gaap	Payments For Restructuring PaymentsForRestructuring	4971000	usd
CY2023	sphr	Restructuring And Related Costs Spinoff Transfers RestructuringAndRelatedCostsSpinoffTransfers	5944000	usd
CY2023Q2	us-gaap	Restructuring Reserve RestructuringReserve	8891000	usd
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	333653000	usd
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-52297000	usd
CY2021	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-171142000	usd
CY2023	sphr	Stockholders Equity Transferof Assetsand Liabilities StockholdersEquityTransferofAssetsandLiabilities	0	usd
CY2022	sphr	Stockholders Equity Transferof Assetsand Liabilities StockholdersEquityTransferofAssetsandLiabilities	-3173000	usd
CY2021	sphr	Stockholders Equity Transferof Assetsand Liabilities StockholdersEquityTransferofAssetsandLiabilities	-8728000	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	330745000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-59718000	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-161502000	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	34651000	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	34255000	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	34077000	shares
CY2023	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	278000	shares
CY2022	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2021	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	175000	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	34929000	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	34255000	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	34252000	shares
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	800000	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1207000	shares
CY2023	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	4.96
CY2022	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-4.02
CY2021	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.14
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	9.55
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-1.75
CY2021	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-4.74
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	14.51
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-5.77
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-4.60
CY2023	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	4.93
CY2022	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-4.02
CY2021	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.13
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	9.47
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-1.75
CY2021	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-4.72
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	14.40
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-5.77
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-4.59
CY2021	us-gaap	Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount	0	usd
CY2023Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3394989000	usd
CY2022Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2221064000	usd
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	87828000	usd
CY2022Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	63487000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3307161000	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2157577000	usd
CY2023	us-gaap	Cost Depreciation Amortization And Depletion CostDepreciationAmortizationAndDepletion	27601000	usd
CY2022	us-gaap	Cost Depreciation Amortization And Depletion CostDepreciationAmortizationAndDepletion	16794000	usd
CY2021	us-gaap	Cost Depreciation Amortization And Depletion CostDepreciationAmortizationAndDepletion	13146000	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	84912000	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	66151000	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	10127000	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	6553000	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	110259000	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	84420000	usd
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	120386000	usd
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	90973000	usd
CY2023	us-gaap	Lease Cost LeaseCost	17602000	usd
CY2022	us-gaap	Lease Cost LeaseCost	18284000	usd
CY2021	us-gaap	Lease Cost LeaseCost	21576000	usd
CY2023	sphr	Lessee Ground Lease Termof Objectives After Tax Cash Flowin Excessof Objective Percent LesseeGroundLeaseTermofObjectivesAfterTaxCashFlowinExcessofObjectivePercent	0.25
CY2023Q2	sphr	Lessee Ground Lease Funding LesseeGroundLeaseFunding	75000000	usd
CY2023	sphr	Lessee Ground Lease Construction Costs Paid LesseeGroundLeaseConstructionCostsPaid	65000000	usd
CY2023	sphr	Lessee Ground Lease Termof Contract LesseeGroundLeaseTermofContract	P50Y
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	12332000	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	14400000	usd
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	16603000	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	6435000	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	43834000	usd
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	19182000	usd
CY2022	us-gaap	Payments For Proceeds From Tenant Allowance PaymentsForProceedsFromTenantAllowance	-17697000	usd
CY2021	us-gaap	Payments For Proceeds From Tenant Allowance PaymentsForProceedsFromTenantAllowance	0	usd
CY2023	us-gaap	Payments For Proceeds From Tenant Allowance PaymentsForProceedsFromTenantAllowance	0	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	10489000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	17174000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	14657000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	11382000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	11570000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	119439000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	184711000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	64325000	usd
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	120386000	usd
CY2023Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P12Y1M6D
CY2022Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y2M12D
CY2023Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0538
CY2022Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0078
CY2021Q2	us-gaap	Goodwill Goodwill	456807000	usd
CY2022	us-gaap	Goodwill Period Increase Decrease GoodwillPeriodIncreaseDecrease	0	usd
CY2022Q2	us-gaap	Goodwill Goodwill	456807000	usd
CY2023	us-gaap	Goodwill Period Increase Decrease GoodwillPeriodIncreaseDecrease	0	usd
CY2023Q2	us-gaap	Goodwill Goodwill	456807000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	83044000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	83044000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	65134000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	62019000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	17910000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	21025000	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3115000	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5768000	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3460000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	3115000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	3115000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	3115000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	3115000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	3115000	usd
CY2023Q2	us-gaap	Contractual Obligation Due In Next Twelve Months ContractualObligationDueInNextTwelveMonths	275891000	usd
CY2023Q2	us-gaap	Contractual Obligation Due In Second Year ContractualObligationDueInSecondYear	255430000	usd
CY2023Q2	us-gaap	Contractual Obligation Due In Third Year ContractualObligationDueInThirdYear	254780000	usd
CY2023Q2	us-gaap	Contractual Obligation Due In Fourth Year ContractualObligationDueInFourthYear	260066000	usd
CY2023Q2	us-gaap	Contractual Obligation Due In Fifth Year ContractualObligationDueInFifthYear	269134000	usd
CY2023Q2	us-gaap	Contractual Obligation Due After Fifth Year ContractualObligationDueAfterFifthYear	1819583000	usd
CY2023Q2	us-gaap	Contractual Obligation ContractualObligation	3134884000	usd
CY2023	sphr	Loss Contingency Number Of Complaints Filed LossContingencyNumberOfComplaintsFiled	15	complaint
CY2023Q2	sphr	Loss Contingency Remaining Claims Filed Involving Fiduciary Breaches LossContingencyRemainingClaimsFiledInvolvingFiduciaryBreaches	2	complaint
CY2021Q3	us-gaap	Loss Contingency New Claims Filed Number LossContingencyNewClaimsFiledNumber	2	complaint
CY2021Q3	sphr	Loss Contingency Number Of Consolidated Claims LossContingencyNumberOfConsolidatedClaims	4	complaint
CY2023Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	82500000	usd
CY2022Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	66000000	usd
CY2023Q2	us-gaap	Long Term Debt LongTermDebt	1207250000	usd
CY2023Q2	sphr	Total Long Term Debt Carrying Value TotalLongTermDebtCarryingValue	1207250000	usd
CY2023Q2	sphr	Total Long Term Debt Fair Value TotalLongTermDebtFairValue	1199839000	usd
CY2022Q2	sphr	Total Long Term Debt Carrying Value TotalLongTermDebtCarryingValue	998250000	usd
CY2022Q2	sphr	Total Long Term Debt Fair Value TotalLongTermDebtFairValue	958320000	usd
CY2023Q2	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	6363000	usd
CY2023Q2	sphr	Defined Benefit Plan Number Of Sponsored Plans DefinedBenefitPlanNumberOfSponsoredPlans	2	plan
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	172000	usd
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	139000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	4678000	usd
CY2023Q2	us-gaap	Defined Benefit Plan Weighted Average Asset Allocations DefinedBenefitPlanWeightedAverageAssetAllocations	1
CY2022Q2	us-gaap	Defined Benefit Plan Weighted Average Asset Allocations DefinedBenefitPlanWeightedAverageAssetAllocations	1
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	320000	usd
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	962000	usd
CY2023	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	891000	usd
CY2023Q2	us-gaap	Defined Benefit Plan Fair Value Of Plan Assets DefinedBenefitPlanFairValueOfPlanAssets	17976000	usd
CY2022Q2	us-gaap	Defined Benefit Plan Fair Value Of Plan Assets DefinedBenefitPlanFairValueOfPlanAssets	18756000	usd
CY2023Q2	us-gaap	Defined Benefit Plan Funded Percentage DefinedBenefitPlanFundedPercentage	0.05
CY2023	us-gaap	Defined Benefit Plan Amortization Of Gains Losses DefinedBenefitPlanAmortizationOfGainsLosses	83000	usd
CY2023Q2	us-gaap	Deferred Compensation Plan Assets DeferredCompensationPlanAssets	1087000	usd
CY2023Q2	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	1087000	usd
CY2023	sphr	Number Of Share Based Compensation Plans NumberOfShareBasedCompensationPlans	3	plan
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P3Y
CY2023Q2	sphr	Number Of Equity Award Options NumberOfEquityAwardOptions	2	option
CY2023Q2	sphr	Share Based Compensation Arrangement By Share Based Payment Award Threshold Trading Days ShareBasedCompensationArrangementByShareBasedPaymentAwardThresholdTradingDays	10	d
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	75.70
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	50.81
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	72.32
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	63.82
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	63.74
CY2020Q2	sphr	Number Of Share Based Compensation Plans NumberOfShareBasedCompensationPlans	2	plan
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	57840000	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-35213000	usd
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	9142000	usd
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	35656000	usd
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-3970000	usd
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	9222000	usd
CY2023	sphr	Effective Income Tax Rate Reconciliation Changein Estimated Applicable Corporate Tax Rate Usedto Determine Deferred Taxes EffectiveIncomeTaxRateReconciliationChangeinEstimatedApplicableCorporateTaxRateUsedtoDetermineDeferredTaxes	1286000	usd
CY2022	sphr	Effective Income Tax Rate Reconciliation Changein Estimated Applicable Corporate Tax Rate Usedto Determine Deferred Taxes EffectiveIncomeTaxRateReconciliationChangeinEstimatedApplicableCorporateTaxRateUsedtoDetermineDeferredTaxes	-1732000	usd
CY2021	sphr	Effective Income Tax Rate Reconciliation Changein Estimated Applicable Corporate Tax Rate Usedto Determine Deferred Taxes EffectiveIncomeTaxRateReconciliationChangeinEstimatedApplicableCorporateTaxRateUsedtoDetermineDeferredTaxes	5332000	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-2053000	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-2200000	usd
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	4863000	usd
CY2023	sphr	Effective Income Tax Rate Reconciliation Nondeductible Expense Officer Compensation Amountof Tax Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOfficerCompensationAmountofTaxExpense	4814000	usd
CY2022	sphr	Effective Income Tax Rate Reconciliation Nondeductible Expense Officer Compensation Amountof Tax Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOfficerCompensationAmountofTaxExpense	12759000	usd
CY2021	sphr	Effective Income Tax Rate Reconciliation Nondeductible Expense Officer Compensation Amountof Tax Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOfficerCompensationAmountofTaxExpense	9646000	usd
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	291000	usd
CY2022	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	34000	usd
CY2021	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-399000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	103403000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-29830000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	38907000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	26684000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	172595000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	0	usd
CY2022Q2	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	2682000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits	27349000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits	14335000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	9231000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	11931000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deferred Rent DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent	11040000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deferred Rent DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent	7250000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Investments DeferredTaxAssetsInvestments	0	usd
CY2022Q2	us-gaap	Deferred Tax Assets Investments DeferredTaxAssetsInvestments	26946000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	14991000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	0	usd
CY2023Q2	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	3694000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	2251000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	92989000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	237990000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	30000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2923000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	92959000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	235067000	usd
CY2023Q2	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	264800000	usd
CY2022Q2	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	264605000	usd
CY2023Q2	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	105405000	usd
CY2022Q2	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	109556000	usd
CY2023Q2	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	5870000	usd
CY2022Q2	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	2091000	usd
CY2023Q2	us-gaap	Deferred Tax Liabilities Investments DeferredTaxLiabilitiesInvestments	12474000	usd
CY2022Q2	us-gaap	Deferred Tax Liabilities Investments DeferredTaxLiabilitiesInvestments	3206000	usd
CY2023Q2	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	83962000	usd
CY2022Q2	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	0	usd
CY2023Q2	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	472511000	usd
CY2022Q2	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	379458000	usd
CY2023Q2	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	379552000	usd
CY2022Q2	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	144391000	usd
CY2023Q2	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	119000000	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	7288000	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-1014000	usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	101972000	usd
CY2023	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2023Q2	us-gaap	Other Assets Current OtherAssetsCurrent	4344000	usd
CY2022Q2	us-gaap	Other Assets Current OtherAssetsCurrent	5874000	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	131965000	usd
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	747313000	usd
CY2023Q2	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	297149000	usd
CY2022Q2	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	12999000	usd
CY2023Q2	sphr	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Continuing Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsContinuingOperations	429114000	usd
CY2022Q2	sphr	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Continuing Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsContinuingOperations	760312000	usd
CY2023Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	22616000	usd
CY2022Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	10647000	usd
CY2023Q2	us-gaap	Prepaid Taxes PrepaidTaxes	834000	usd
CY2022Q2	us-gaap	Prepaid Taxes PrepaidTaxes	4510000	usd
CY2023Q2	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	21453000	usd
CY2022Q2	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	2404000	usd
CY2023Q2	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	314000	usd
CY2022Q2	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	0	usd
CY2023Q2	us-gaap	Deferred Costs Current DeferredCostsCurrent	6524000	usd
CY2022Q2	us-gaap	Deferred Costs Current DeferredCostsCurrent	3427000	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	56085000	usd
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	26862000	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	39654000	usd
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	2014000	usd
CY2023Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	75579000	usd
CY2022Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	46221000	usd
CY2023Q2	sphr	Cash Due To Promoters CashDueToPromoters	73611000	usd
CY2022Q2	sphr	Cash Due To Promoters CashDueToPromoters	0	usd
CY2023Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	11842000	usd
CY2022Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	0	usd
CY2023Q2	sphr	Capital Expenditure Accruals CapitalExpenditureAccruals	236593000	usd
CY2022Q2	sphr	Capital Expenditure Accruals CapitalExpenditureAccruals	204894000	usd
CY2023Q2	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	53857000	usd
CY2022Q2	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	6970000	usd
CY2023Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	24595000	usd
CY2022Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	16459000	usd
CY2023	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	1969000	usd
CY2022	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	0	usd
CY2021	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	1252000	usd
CY2023	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-8184000	usd
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-4863000	usd
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-4828000	usd
CY2023	sphr	Other Income Expense OtherIncomeExpense	-2613000	usd
CY2022	sphr	Other Income Expense OtherIncomeExpense	-655000	usd
CY2021	sphr	Other Income Expense OtherIncomeExpense	-359000	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	536887000	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-5518000	usd
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-3935000	usd
CY2022Q3	us-gaap	Revenues Revenues	123129000	usd
CY2022Q4	us-gaap	Revenues Revenues	159541000	usd
CY2023Q1	us-gaap	Revenues Revenues	162062000	usd
CY2023Q2	us-gaap	Revenues Revenues	129099000	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	174184000	usd
CY2022Q4	us-gaap	Operating Expenses OperatingExpenses	209276000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	263969000	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	199444000	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-51055000	usd
CY2022Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-49735000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-101907000	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-70345000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-23158000	usd
CY2022Q4	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-50453000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-113999000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	359637000	usd
CY2022Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	2236000	usd
CY2022Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	97889000	usd
CY2023Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	55441000	usd
CY2023Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	178087000	usd
CY2022Q3	us-gaap	Profit Loss ProfitLoss	-20922000	usd
CY2022Q4	us-gaap	Profit Loss ProfitLoss	47436000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-58558000	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	537724000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-21636000	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	44463000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-56850000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	536795000	usd
CY2021Q3	us-gaap	Revenues Revenues	141473000	usd
CY2021Q4	us-gaap	Revenues Revenues	160753000	usd
CY2022Q1	us-gaap	Revenues Revenues	168080000	usd
CY2022Q2	us-gaap	Revenues Revenues	139749000	usd
CY2021Q3	us-gaap	Operating Expenses OperatingExpenses	193897000	usd
CY2021Q4	us-gaap	Operating Expenses OperatingExpenses	190029000	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	190268000	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	201598000	usd
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-52424000	usd
CY2021Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-29276000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-22188000	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-61849000	usd
CY2021Q3	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-37337000	usd
CY2021Q4	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-21941000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-27021000	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-51551000	usd
CY2021Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-39318000	usd
CY2021Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	26959000	usd
CY2022Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	7715000	usd
CY2022Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-47653000	usd
CY2021Q3	us-gaap	Profit Loss ProfitLoss	-76655000	usd
CY2021Q4	us-gaap	Profit Loss ProfitLoss	5018000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-19306000	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	-99204000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-79232000	usd
CY2021Q4	us-gaap	Net Income Loss NetIncomeLoss	2270000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-17491000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-99942000	usd
CY2021Q3	sphr	Stockholders Equity Transferof Assetsand Liabilities StockholdersEquityTransferofAssetsandLiabilities	0	usd
CY2021Q4	sphr	Stockholders Equity Transferof Assetsand Liabilities StockholdersEquityTransferofAssetsandLiabilities	0	usd
CY2022Q1	sphr	Stockholders Equity Transferof Assetsand Liabilities StockholdersEquityTransferofAssetsandLiabilities	0	usd
CY2022Q2	sphr	Stockholders Equity Transferof Assetsand Liabilities StockholdersEquityTransferofAssetsandLiabilities	3173000	usd
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-79232000	usd
CY2021Q4	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	2270000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-17491000	usd
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-103115000	usd

Files In Submission

Name	View Source	Status
0001795250-23-000017-index-headers.html	Edgar Link	pending
0001795250-23-000017-index.html	Edgar Link	pending
0001795250-23-000017.txt	Edgar Link	pending
0001795250-23-000017-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R108.htm	Edgar Link	pending
R109.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R110.htm	Edgar Link	pending
R111.htm	Edgar Link	pending
R112.htm	Edgar Link	pending
R113.htm	Edgar Link	pending
R114.htm	Edgar Link	pending
R115.htm	Edgar Link	pending
R116.htm	Edgar Link	pending
R117.htm	Edgar Link	pending
R118.htm	Edgar Link	pending
R119.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R120.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
sphr-20230630.htm	Edgar Link	pending
sphr-20230630.xsd	Edgar Link	pending
sphr-20230630_g1.jpg	Edgar Link	pending
sphr-20230630_g2.jpg	Edgar Link	pending
sphrex1028-davidgranvillex.htm	Edgar Link	pending
sphrex1031-sphrxoverlappol.htm	Edgar Link	pending
sphrex1044-secondamendme.htm	Edgar Link	pending
sphrex1044-secondamendme001.jpg	Edgar Link	pending
sphrex1044-secondamendme002.jpg	Edgar Link	pending
sphrex1044-secondamendme003.jpg	Edgar Link	pending
sphrex1044-secondamendme004.jpg	Edgar Link	pending
sphrex1044-secondamendme005.jpg	Edgar Link	pending
sphr-20230630_def.xml	Edgar Link	unprocessable
sphr-20230630_pre.xml	Edgar Link	unprocessable
sphr-20230630_htm.xml	Edgar Link	completed
sphrex1044-secondamendme006.jpg	Edgar Link	pending
sphrex1044-secondamendme007.jpg	Edgar Link	pending
sphrex1044-secondamendme008.jpg	Edgar Link	pending
sphrex1044-secondamendme009.jpg	Edgar Link	pending
sphrex1044-secondamendme010.jpg	Edgar Link	pending
sphrex1044-secondamendme011.jpg	Edgar Link	pending
sphrex1044-secondamendme012.jpg	Edgar Link	pending
sphrex1044-secondamendme013.jpg	Edgar Link	pending
sphrex1044-secondamendme014.jpg	Edgar Link	pending
sphrex1044-secondamendme015.jpg	Edgar Link	pending
sphrex1044-secondamendme016.jpg	Edgar Link	pending
sphrex1044-secondamendme017.jpg	Edgar Link	pending
sphrex1044-secondamendme018.jpg	Edgar Link	pending
sphrex1044-secondamendme019.jpg	Edgar Link	pending
sphrex1044-secondamendme020.jpg	Edgar Link	pending
sphrex1044-secondamendme021.jpg	Edgar Link	pending
sphrex1044-secondamendme022.jpg	Edgar Link	pending
sphrex1044-secondamendme023.jpg	Edgar Link	pending
sphrex1044-secondamendme024.jpg	Edgar Link	pending
sphrex1044-secondamendme025.jpg	Edgar Link	pending
sphrex1044-secondamendme026.jpg	Edgar Link	pending
sphrex1044-secondamendme027.jpg	Edgar Link	pending
sphrex1044-secondamendme028.jpg	Edgar Link	pending
sphrex1044-secondamendme029.jpg	Edgar Link	pending
sphrex1044-secondamendme030.jpg	Edgar Link	pending
sphrex1044-secondamendme031.jpg	Edgar Link	pending
sphrex1044-secondamendme032.jpg	Edgar Link	pending
sphrex1044-secondamendme033.jpg	Edgar Link	pending
sphrex1044-secondamendme034.jpg	Edgar Link	pending
sphrex1044-secondamendme035.jpg	Edgar Link	pending
sphrex1044-secondamendme036.jpg	Edgar Link	pending
sphrex1044-secondamendme037.jpg	Edgar Link	pending
sphrex1044-secondamendme038.jpg	Edgar Link	pending
sphrex1044-secondamendme039.jpg	Edgar Link	pending
sphrex1044-secondamendme040.jpg	Edgar Link	pending
sphrex1044-secondamendme041.jpg	Edgar Link	pending
sphrex1044-secondamendme042.jpg	Edgar Link	pending
sphrex1044-secondamendme043.jpg	Edgar Link	pending
sphrex1044-secondamendme044.jpg	Edgar Link	pending
sphrex1044-secondamendme045.jpg	Edgar Link	pending
sphrex1044-secondamendme046.jpg	Edgar Link	pending
sphrex1044-secondamendme047.jpg	Edgar Link	pending
sphrex1044-secondamendme048.jpg	Edgar Link	pending
sphrex1044-secondamendme049.jpg	Edgar Link	pending
sphrex1044-secondamendme050.jpg	Edgar Link	pending
sphrex1044-secondamendme051.jpg	Edgar Link	pending
sphrex1044-secondamendme052.jpg	Edgar Link	pending
sphrex1044-secondamendme053.jpg	Edgar Link	pending
sphrex1044-secondamendme054.jpg	Edgar Link	pending
sphrex1044-secondamendme055.jpg	Edgar Link	pending
sphrex1044-secondamendme056.jpg	Edgar Link	pending
sphrex1044-secondamendme057.jpg	Edgar Link	pending
sphrex1044-secondamendme058.jpg	Edgar Link	pending
sphrex1044-secondamendme059.jpg	Edgar Link	pending
sphrex1044-secondamendme060.jpg	Edgar Link	pending
sphrex1044-secondamendme061.jpg	Edgar Link	pending
sphrex1044-secondamendme062.jpg	Edgar Link	pending
sphrex1044-secondamendme063.jpg	Edgar Link	pending
sphrex1044-secondamendme064.jpg	Edgar Link	pending
sphrex1044-secondamendme065.jpg	Edgar Link	pending
sphrex1044-secondamendme066.jpg	Edgar Link	pending
sphrex1044-secondamendme067.jpg	Edgar Link	pending
sphrex1044-secondamendme068.jpg	Edgar Link	pending
sphrex1044-secondamendme069.jpg	Edgar Link	pending
sphrex1044-secondamendme070.jpg	Edgar Link	pending
sphrex1044-secondamendme071.jpg	Edgar Link	pending
sphrex1044-secondamendme072.jpg	Edgar Link	pending
sphrex1044-secondamendme073.jpg	Edgar Link	pending
sphrex1044-secondamendme074.jpg	Edgar Link	pending
sphrex1044-secondamendme075.jpg	Edgar Link	pending
sphrex1044-secondamendme076.jpg	Edgar Link	pending
sphrex1044-secondamendme077.jpg	Edgar Link	pending
sphrex1044-secondamendme078.jpg	Edgar Link	pending
sphrex1044-secondamendme079.jpg	Edgar Link	pending
sphrex1044-secondamendme080.jpg	Edgar Link	pending
sphrex1044-secondamendme081.jpg	Edgar Link	pending
sphrex1044-secondamendme082.jpg	Edgar Link	pending
sphrex1044-secondamendme083.jpg	Edgar Link	pending
sphrex1044-secondamendme084.jpg	Edgar Link	pending
sphrex1044-secondamendme085.jpg	Edgar Link	pending
sphrex1044-secondamendme086.jpg	Edgar Link	pending
sphrex1044-secondamendme087.jpg	Edgar Link	pending
sphrex1044-secondamendme088.jpg	Edgar Link	pending
sphrex1044-secondamendme089.jpg	Edgar Link	pending
sphrex1044-secondamendme090.jpg	Edgar Link	pending
sphrex1044-secondamendme091.jpg	Edgar Link	pending
sphrex1044-secondamendme092.jpg	Edgar Link	pending
sphrex1044-secondamendme093.jpg	Edgar Link	pending
sphrex1044-secondamendme094.jpg	Edgar Link	pending
sphrex1044-secondamendme095.jpg	Edgar Link	pending
sphrex1044-secondamendme096.jpg	Edgar Link	pending
sphrex1044-secondamendme097.jpg	Edgar Link	pending
sphrex1044-secondamendme098.jpg	Edgar Link	pending
sphrex1044-secondamendme099.jpg	Edgar Link	pending
sphrex1044-secondamendme100.jpg	Edgar Link	pending
sphrex1044-secondamendme101.jpg	Edgar Link	pending
sphrex1044-secondamendme102.jpg	Edgar Link	pending
sphrex1044-secondamendme103.jpg	Edgar Link	pending
sphrex1044-secondamendme104.jpg	Edgar Link	pending
sphrex1044-secondamendme105.jpg	Edgar Link	pending
sphrex1044-secondamendme106.jpg	Edgar Link	pending
sphrex1044-secondamendme107.jpg	Edgar Link	pending
sphrex1044-secondamendme108.jpg	Edgar Link	pending
sphrex1044-secondamendme109.jpg	Edgar Link	pending
sphrex1044-secondamendme110.jpg	Edgar Link	pending
sphrex1044-secondamendme111.jpg	Edgar Link	pending
sphrex1044-secondamendme112.jpg	Edgar Link	pending
sphrex1044-secondamendme113.jpg	Edgar Link	pending
sphrex1044-secondamendme114.jpg	Edgar Link	pending
sphrex1044-secondamendme115.jpg	Edgar Link	pending
sphrex1044-secondamendme116.jpg	Edgar Link	pending
sphrex1044-secondamendme117.jpg	Edgar Link	pending
sphrex1044-secondamendme118.jpg	Edgar Link	pending
sphrex1044-secondamendme119.jpg	Edgar Link	pending
sphrex1044-secondamendme120.jpg	Edgar Link	pending
sphrex1044-secondamendme121.jpg	Edgar Link	pending
sphrex1044-secondamendme122.jpg	Edgar Link	pending
sphrex1044-secondamendme123.jpg	Edgar Link	pending
sphrex1044-secondamendme124.jpg	Edgar Link	pending
sphrex1044-secondamendme125.jpg	Edgar Link	pending
sphrex1044-secondamendme126.jpg	Edgar Link	pending
sphrex1044-secondamendme127.jpg	Edgar Link	pending
sphrex1044-secondamendme128.jpg	Edgar Link	pending
sphrex1044-secondamendme129.jpg	Edgar Link	pending
sphrex1044-secondamendme130.jpg	Edgar Link	pending
sphrex1044-secondamendme131.jpg	Edgar Link	pending
sphrex1044-secondamendme132.jpg	Edgar Link	pending
sphrex1044-secondamendme133.jpg	Edgar Link	pending
sphrex1044-secondamendme134.jpg	Edgar Link	pending
sphrex1044-secondamendme135.jpg	Edgar Link	pending
sphrex1044-secondamendme136.jpg	Edgar Link	pending
sphrex1044-secondamendme137.jpg	Edgar Link	pending
sphrex1044-secondamendme138.jpg	Edgar Link	pending
sphrex1044-secondamendme139.jpg	Edgar Link	pending
sphrex1044-secondamendme140.jpg	Edgar Link	pending
sphrex1044-secondamendme141.jpg	Edgar Link	pending
sphrex1044-secondamendme142.jpg	Edgar Link	pending
sphrex1044-secondamendme143.jpg	Edgar Link	pending
sphrex1044-secondamendme144.jpg	Edgar Link	pending
sphrex1044-secondamendme145.jpg	Edgar Link	pending
sphrex1044-secondamendme146.jpg	Edgar Link	pending
sphrex1044-secondamendme147.jpg	Edgar Link	pending
sphrex1044-secondamendme148.jpg	Edgar Link	pending
sphrex1044-secondamendme149.jpg	Edgar Link	pending
sphrex1044-secondamendme150.jpg	Edgar Link	pending
sphrex1044-secondamendme151.jpg	Edgar Link	pending
sphrex1044-secondamendme152.jpg	Edgar Link	pending
sphrex1044-secondamendme153.jpg	Edgar Link	pending
sphrex1044-secondamendme154.jpg	Edgar Link	pending
sphrex1044-secondamendme155.jpg	Edgar Link	pending
sphrex1044-secondamendme156.jpg	Edgar Link	pending
sphrex1044-secondamendme157.jpg	Edgar Link	pending
sphrex1044-secondamendme158.jpg	Edgar Link	pending
sphrex1044-secondamendme159.jpg	Edgar Link	pending
sphrex1044-secondamendme160.jpg	Edgar Link	pending
sphrex1044-secondamendme161.jpg	Edgar Link	pending
sphrex1044-secondamendme162.jpg	Edgar Link	pending
sphrex1044-secondamendme163.jpg	Edgar Link	pending
sphrex1044-secondamendme164.jpg	Edgar Link	pending
sphrex1044-secondamendme165.jpg	Edgar Link	pending
sphrex1044-secondamendme166.jpg	Edgar Link	pending
sphrex1044-secondamendme167.jpg	Edgar Link	pending
sphrex1044-secondamendme168.jpg	Edgar Link	pending
sphrex1044-secondamendme169.jpg	Edgar Link	pending
sphrex1044-secondamendme170.jpg	Edgar Link	pending
sphrex1044-secondamendme171.jpg	Edgar Link	pending
sphrex1044-secondamendme172.jpg	Edgar Link	pending
sphrex1044-secondamendme173.jpg	Edgar Link	pending
sphrex1044-secondamendme174.jpg	Edgar Link	pending
sphrex1044-secondamendme175.jpg	Edgar Link	pending
sphrex1044-secondamendme176.jpg	Edgar Link	pending
sphrex1044-secondamendme177.jpg	Edgar Link	pending
sphrex1044-secondamendme178.jpg	Edgar Link	pending
sphrex1044-secondamendme179.jpg	Edgar Link	pending
sphrex1044-secondamendme180.jpg	Edgar Link	pending
sphrex1044-secondamendme181.jpg	Edgar Link	pending
sphrex1044-secondamendme182.jpg	Edgar Link	pending
sphrex1044-secondamendme183.jpg	Edgar Link	pending
sphrex45-descriptionofcapi.htm	Edgar Link	pending
sphrexhibit2110630202310k.htm	Edgar Link	pending
sphrexhibit23106302023.htm	Edgar Link	pending
sphrexhibit23206302023.htm	Edgar Link	pending
sphrexhibit3110630202310k.htm	Edgar Link	pending
sphrexhibit3120630202310k.htm	Edgar Link	pending
sphrexhibit3210630202310k.htm	Edgar Link	pending
sphrexhibit3220630202310k.htm	Edgar Link	pending
sphr-20230630_cal.xml	Edgar Link	unprocessable
sphr-20230630_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SPHR
Sphere Entertainment Co. Stock $sphr

2023 Q2 Form 10-K Financial Statement

#000179525023000017 Filed on August 22, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SPHR Sphere Entertainment Co. Stock $sphr

2023 Q2 Form 10-K Financial Statement

#000179525023000017 Filed on August 22, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SPHR
Sphere Entertainment Co. Stock $sphr